Twitter

New article in @InfectDiseaseAd: "HCV is the most common blood-borne virus for which there is no vaccine. […] The d… https://t.co/MpgB8HkwjP — 2 days 4 hours ago
@oxfordtimes showcasing great hep C work in Oxfordshire! "I initiated co-ordinated collaborative teamwork with oth… https://t.co/WENe8OkkLT — 3 days 4 hours ago
A new study in the Harm Reduction Journal has found that a project in Holland has been successful in better linking… https://t.co/jIyr2WZxF5 — 4 days 3 hours ago
RT @ijdrugpolicy: Evidence-making hepatitis C cure: Towards a science that knows more carefully https://t.co/VMVPP6S7aE — 5 days 3 hours ago
Using pharmacists to distribute HCV treatment was discussed at our national ODN conference recently. Read more abou… https://t.co/ZfOySNyNQK — 6 days 3 hours ago

Join the HCV Action network for our free monthly email update

Characteristics of an ideal Hepatitis C service - summary paper

Download

Published Jan 2010 by Commissioning Business Service (cbs) and NHS Commissioning Business Service

Format PDF

In this paper Siobhan Fahey, the Greater Manchester Programme lead for Hepatitis C, and Julie Cunningham, commissioning manager within the Commissioning Business Service (CBS), review the processes undertaken in engaging with stakeholder groups during the Greater Manchester HCV strategy. Stakeholder groups were given the opportunity to comment on what they thought were the key characteristics of an ideal Hepatitis C service in relation to the various parts of the care pathway. It outlines the key stages and discussion that have taken place regarding the development of the characteristics of a Hepatitis C service.

Types Case study, Reports & Research, Tools & Templates, Strategy & Planning

Regions North West

Themes Testing & Diagnosis, Treatment & Care

Audiences Medical professional, Commissioner

Related resources

Drug-related infectious diseases in Europe

This report from the European Monitoring Centre for Drugs and Drug Addiction provides an overview of infectious disease surveillance data, outbreak investigations, and prevention and control measures among people who inject drugs in Europe up to February 2019, including viral hepatitis.

UK, Rest of World 16 Jul 2019 Reports & Research PDF

Testing & Diagnosis, Treatment & Care, Awareness & Prevention
Evaluating peer-supported screening as a hepatitis C case-finding model in prisoners

This study evaluates peer-supported screening as a model of active HCV case finding within prisons with a secondary aim to describe the HCV cascade among those infected including linkage to care and treatment outcomes. The study was carried out in a medium-security Irish male prison with over 500 inmates. The authors conclude that peer-supported screening is an effective active HCV case-finding model to find and link prisoners with untreated active HCV infection to HCV care.

Rest of World 09 Jul 2019 Reports & Research PDF

Prisons, Testing & Diagnosis, Treatment & Care
Information for GPs on the Infected Blood Inquiry

This document from Public Health England provides information for GPs on the ongoing Infected Blood Inquiry, chaired by Sir Brian Langstaff. The document covers: why there is an Infected Blood Inquiry; what to advise if your patient thinks that they received blood in the 1970s/1980s; what to do if your patient is hepatitis C positive and is concerned a past transfusion

UK 05 Jul 2019 Training, Reports & Research PDF

Testing & Diagnosis, Treatment & Care, Awareness & Prevention
WHO progress report on HIV, viral hepatitis and STIs 2019

The World Health Organisation has published its mid-term report on progress towards implementing the 'Global health sector strategies on HIV, viral hepatitis and sexually transmitted infections'. The UK signed up to the 'Global health sector strategy on viral hepatitis 2016-21', committing to eliminating hepatitis C by 2030. The report highlights the need to strengthen data and update hepatitis data more regularly. It states that global targets for reducing mortality from viral hepatitis will not be met 'without massively accelerating universal access to testing' and treatment.

Rest of World Reports & Research, Strategy & Planning PDF

Testing & Diagnosis, Treatment & Care, Awareness & Prevention
WHO policy brief on access to testing and treatment for people who inject drugs and people in prisons

The World Health Organisation (WHO) published this policy brief in April 2019 to set out the current landscape of country hepatitis policies for harm reduction and hepatitis C testing and treatment for people who inject drugs and people in prisons. It aims to capture how governments are translating the WHO Global health sector strategy on viral hepatitis 2016-2021, which the UK Government has signed up to, in national plans. It also provides a summary of the enablers and barriers to hepatitis C testing and treatment in these populations.

UK, Rest of World Reports & Research, Tools & Templates, Strategy & Planning PDF

Prisons, Testing & Diagnosis, Treatment & Care

Twitter

Join the HCV Action network for our free monthly email update

Characteristics of an ideal Hepatitis C service - summary paper

Download

Related resources

Sponsors

Partners

Search form

Twitter

Join the HCV Action network for our free monthly email update

You are here

Characteristics of an ideal Hepatitis C service - summary paper

Download

Related resources

Sponsors

Partners